From Pulse 2.0 · Amit Chowdhry · · 50s
Labcorp Acquires BioReference Health Assets
Labcorp to buy BioReference Health assets for up to $872 million.
In brief
Labcorp to buy BioReference Health assets for up to $872 million. Labcorp acquires BioReference Health's 4Kscore Test assets for $872 million to expand clinical services. Originally reported by Pulse 2.0.
Acquisition Deal
Labcorp agreed to acquire select BioReference Health assets from OPKO Health for up to $872 million.
Cash and Earnout Terms
The deal includes $722 million in cash at closing and a potential $150 million earnout tied to 4Kscore Test revenue.
4Kscore Test Details
The FDA-approved 4Kscore Test predicts aggressive prostate cancer before biopsy decisions.
Business Expansion
Labcorp will add women’s health, urology, corrections, and broader clinical testing services to its portfolio.
Strategic Rationale
OPKO aims to streamline operations and focus on biopharmaceuticals after the acquisition.
The short version
Labcorp acquires BioReference Health's 4Kscore Test assets for $872 million to expand clinical services.
